Leukemia Clinical Trials

Showing 5581-5600 of 8,366 trials

Rad Predictors for WON

NCT03801070

This is a retrospective chart review study examining 1) demographic data such as age, sex, etiology of pancreatitis 2) clinical data including radiological characteristics of walled off pancreatic necrosis, walled off necrosis related admissions and readmission following endoscopic drainage, surgical or percutaneous procedures performed for the management of walled off pancreatic necrosis, and clinical outcomes following treatment of WON (including hospital readmissions, WON resolution, procedure complications, WON related death) 3) endoscopy data including indication for initial endoscopic drainage and subsequent endoscopic procedures performed for management of walled off necrosis (including additional EGD's, endoscopic drainage procedures, and/or necrosectomy)

Walled Off Pancreatic Necrosis (WON)

Washington University School of Medicine104 participantsStarted Jul 2017

St Louis, Missouri, United States

COMPLETEDPhase 2

A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

NCT01439568

The purpose of this trial is to compare the progression free survival of LY2510924 + carboplatin + etoposide therapy versus carboplatin + etoposide therapy in participants with extensive-stage disease small cell lung cancer (SCLC)

Extensive Stage Small Cell Lung Carcinoma

Eli Lilly and Company90 participantsStarted Sep 2011

Denver, Colorado, United States • Fort Myers, Florida, United States • Orlando, Florida, United States +12 more locations

Rad Predictors for WON

A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma

Related Searches

To Study the Impact of Stopping Therapy in Patients of CML With Molecular Remission

A Study to Assess Programmed Death Ligand-1 (PD-L1) Expression in Cytological Versus Histological Lung Cancer Specimens

Implementation of Hysteroscopy in Flanders and the Netherlands

Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Growth, Safety and Tolerance of a Rice Protein Hydrolysate Formula in Infants With Cow's Milk Protein Allergy

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression

Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma

Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney Function

Effect of Proton Pump Inhibitor of Daily Use for One Month on Kidney Function Test

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Filanesib and Carfilzomib in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

Childhood Origins of Asthma (COAST)

Sirolimus in Combination With MEC in High Risk Myeloid Leukemias

Efficacy of Co-administration of Bilastine and Montelukast in Patients With SARC and Asthma

Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer